Back to results
US 7,396,910 B2Granted
Transient receptor potential channel TRPV3 and its use
AssigneesIrm LLC, Novartis AG
InventorsStuart Bevan, Pamposh Ganju, Peter McIntyre, Ardem Patapoutian, Andrea Peier, Chuanzheng Song
Life of this patent
Estimating the term…
Abstract
This invention provides novel genes and polypeptides of the transient receptor potential channel family, and use of these genes and polypeptides for the treatment of pain and identification of agents useful in the treatment of pain.
Claims3
An isolated TRPV3 polypeptide comprising amino acid residues 1-791 of SEQ ID NO:
- 5 or amino acid residues 2-791 of SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.